시장조사 보고서 : 세계의 파킨슨병 치료제 시장예측 2021년-2026년

■ 영문 제목 : Global Parkinson Disease Drug Market Growth (Status and Outlook) 2021-2026
	■ 상품코드 : LPI-2201K02134 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 113 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의약품

■ 판매가격 / 옵션 (부가세 10% 별도)

Single User (1명 열람용)	USD3,660 ⇒환산￦4,941,000	견적의뢰/주문/질문
Multi User (5명 열람용)	USD5,490 ⇒환산￦7,411,500	견적의뢰/주문/질문
Corporate User (동일기업내 공유가능)	USD7,320 ⇒환산￦9,882,000	견적의뢰/구입/질문

※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.

본 조사보고서는 파킨슨병 치료제의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (시네메트-CR, 트러스탈, 마도파, COMT 저해제, 기타)와 용도별 시장규모 (40세 이하, 40~65세, 65세 이상) 데이터도 수록되어 있습니다.
- 조사 범위
- 경영자용 요약
- 기업별 파킨슨병 치료제 시장 점유율
- 지역별 파킨슨병 치료제 시장규모
- 주요지역의 종류별 시장규모 (시네메트-CR, 트러스탈, 마도파, COMT 저해제, 기타)
- 주요지역의 용도별 시장규모 (40세 이하, 40~65세, 65세 이상)
- 미주의 파킨슨병 치료제 시장규모 (미국, 캐나다, 멕시코, 브라질 등)
- 아시아의 파킨슨병 치료제 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등)
- 유럽의 파킨슨병 치료제 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등)
- 중동/아프리카의 파킨슨병 치료제 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등)
- 시장의 성장요인, 과제, 동향
- 마케팅, 유통업자, 고객리스트
- 세계의 파킨슨병 치료제 시장예측 (2021년-2026년)
- 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익)
Merck, Akorn, GSK, Novartis, Boehringer Ingelheim, Teva Pharmaceutical, Abbvie, Kyowa Hakko Kirin Pharma, Astellas Pharma, Desitin Arzneimittel, Endo Pharmaceuticals, F.Hoffmann-La Roche, H.Lundbeck, Valeant, Apokyn, Orion, Stada Arzneimittel, US WorldMeds, Bausch Health
- 조사의 결과/결론

■ 보고서 개요

According to this latest study, the 2021 growth of Parkinson Disease Drug will have significant change from previous year. By the most conservative estimates of global Parkinson Disease Drug market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Parkinson Disease Drug market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Parkinson Disease Drug market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
Sinemet-CR
Trastal
Madopar
COMT Inhibitor
Other

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Under 40 Years Old
40-65 Years Old
Above 65 Years Old

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Merck
Akorn
GSK
Novartis
Boehringer Ingelheim
Teva Pharmaceutical
Abbvie
Kyowa Hakko Kirin Pharma
Astellas Pharma
Desitin Arzneimittel
Endo Pharmaceuticals
F.Hoffmann-La Roche
H.Lundbeck
Valeant
Apokyn
Orion
Stada Arzneimittel
US WorldMeds
Bausch Health

■ 보고서 목차

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Parkinson Disease Drug Market Size 2016-2026
2.1.2 Parkinson Disease Drug Market Size CAGR by Region 2020 VS 2021 VS 2026
2.2 Parkinson Disease Drug Segment by Type
2.2.1 Sinemet-CR
2.2.2 Sinemet-CR
2.2.3 Madopar
2.2.4 COMT Inhibitor
2.2.5 Other
2.3 Parkinson Disease Drug Market Size by Type
2.3.1 Global Parkinson Disease Drug Market Size CAGR by Type
2.3.2 Global Parkinson Disease Drug Market Size Market Share by Type (2016-2021)
2.4 Parkinson Disease Drug Segment by Application
2.4.1 Under 40 Years Old
2.4.2 40-65 Years Old
2.4.3 Above 65 Years Old
2.5 Parkinson Disease Drug Market Size by Application
2.5.1 Global Parkinson Disease Drug Market Size CAGR by Application
2.5.2 Global Parkinson Disease Drug Market Size Market Share by Application (2016-2021)

3 Parkinson Disease Drug Market Size by Players
3.1 Parkinson Disease Drug Market Size Market Share by Players
3.1.1 Global Parkinson Disease Drug Revenue by Players (2019-2021E)
3.1.2 Global Parkinson Disease Drug Revenue Market Share by Players (2019-2021E)
3.2 Global Parkinson Disease Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Parkinson Disease Drug by Regions
4.1 Parkinson Disease Drug Market Size by Regions (2016-2021)
4.2 Americas Parkinson Disease Drug Market Size Growth (2016-2021)
4.3 APAC Parkinson Disease Drug Market Size Growth (2016-2021)
4.4 Europe Parkinson Disease Drug Market Size Growth (2016-2021)
4.5 Middle East & Africa Parkinson Disease Drug Market Size Growth (2016-2021)

5 Americas
5.1 Americas Parkinson Disease Drug Market Size by Country (2016-2021)
5.2 Americas Parkinson Disease Drug Market Size by Type (2016-2021)
5.3 Americas Parkinson Disease Drug Market Size by Application (2016-2021)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Parkinson Disease Drug Market Size by Region (2016-2021)
6.2 APAC Parkinson Disease Drug Market Size by Type (2016-2021)
6.3 APAC Parkinson Disease Drug Market Size by Application (2016-2021)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Parkinson Disease Drug by Country (2016-2021)
7.2 Europe Parkinson Disease Drug Market Size by Type (2016-2021)
7.3 Europe Parkinson Disease Drug Market Size by Application (2016-2021)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Parkinson Disease Drug by Region (2016-2021)
8.2 Middle East & Africa Parkinson Disease Drug Market Size by Type (2016-2021)
8.3 Middle East & Africa Parkinson Disease Drug Market Size by Application (2016-2021)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Parkinson Disease Drug Market Forecast
10.1 Global Parkinson Disease Drug Forecast by Regions (2021-2026)
10.1.1 Global Parkinson Disease Drug Forecast by Regions (2021-2026)
10.1.2 Americas Parkinson Disease Drug Forecast
10.1.3 APAC Parkinson Disease Drug Forecast
10.1.4 Europe Parkinson Disease Drug Forecast
10.1.5 Middle East & Africa Parkinson Disease Drug Forecast
10.2 Americas Parkinson Disease Drug Forecast by Countries (2021-2026)
10.2.1 United States Parkinson Disease Drug Market Forecast
10.2.2 Canada Parkinson Disease Drug Market Forecast
10.2.3 Mexico Parkinson Disease Drug Market Forecast
10.2.4 Brazil Parkinson Disease Drug Market Forecast
10.3 APAC Parkinson Disease Drug Forecast by Region (2021-2026)
10.3.1 China Parkinson Disease Drug Market Forecast
10.3.2 Japan Parkinson Disease Drug Market Forecast
10.3.3 Korea Parkinson Disease Drug Market Forecast
10.3.4 Southeast Asia Parkinson Disease Drug Market Forecast
10.3.5 India Parkinson Disease Drug Market Forecast
10.3.6 Australia Parkinson Disease Drug Market Forecast
10.4 Europe Parkinson Disease Drug Forecast by Country (2021-2026)
10.4.1 Germany Parkinson Disease Drug Market Forecast
10.4.2 France Parkinson Disease Drug Market Forecast
10.4.3 UK Parkinson Disease Drug Market Forecast
10.4.4 Italy Parkinson Disease Drug Market Forecast
10.4.5 Russia Parkinson Disease Drug Market Forecast
10.5 Middle East & Africa Parkinson Disease Drug Forecast by Region (2021-2026)
10.5.1 Egypt Parkinson Disease Drug Market Forecast
10.5.2 South Africa Parkinson Disease Drug Market Forecast
10.5.3 Israel Parkinson Disease Drug Market Forecast
10.5.4 Turkey Parkinson Disease Drug Market Forecast
10.5.5 GCC Countries Parkinson Disease Drug Market Forecast
10.6 Global Parkinson Disease Drug Forecast by Type (2021-2026)
10.7 Global Parkinson Disease Drug Forecast by Application (2021-2026)

11 Key Players Analysis
11.1 Merck
11.1.1 Merck Company Information
11.1.2 Merck Parkinson Disease Drug Product Offered
11.1.3 Merck Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2021)
11.1.4 Merck Main Business Overview
11.1.5 Merck Latest Developments
11.2 Akorn
11.2.1 Akorn Company Information
11.2.2 Akorn Parkinson Disease Drug Product Offered
11.2.3 Akorn Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2021)
11.2.4 Akorn Main Business Overview
11.2.5 Akorn Latest Developments
11.3 GSK
11.3.1 GSK Company Information
11.3.2 GSK Parkinson Disease Drug Product Offered
11.3.3 GSK Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2021)
11.3.4 GSK Main Business Overview
11.3.5 GSK Latest Developments
11.4 Novartis
11.4.1 Novartis Company Information
11.4.2 Novartis Parkinson Disease Drug Product Offered
11.4.3 Novartis Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2021)
11.4.4 Novartis Main Business Overview
11.4.5 Novartis Latest Developments
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Information
11.5.2 Boehringer Ingelheim Parkinson Disease Drug Product Offered
11.5.3 Boehringer Ingelheim Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2021)
11.5.4 Boehringer Ingelheim Main Business Overview
11.5.5 Boehringer Ingelheim Latest Developments
11.6 Teva Pharmaceutical
11.6.1 Teva Pharmaceutical Company Information
11.6.2 Teva Pharmaceutical Parkinson Disease Drug Product Offered
11.6.3 Teva Pharmaceutical Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2021)
11.6.4 Teva Pharmaceutical Main Business Overview
11.6.5 Teva Pharmaceutical Latest Developments
11.7 Abbvie
11.7.1 Abbvie Company Information
11.7.2 Abbvie Parkinson Disease Drug Product Offered
11.7.3 Abbvie Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2021)
11.7.4 Abbvie Main Business Overview
11.7.5 Abbvie Latest Developments
11.8 Kyowa Hakko Kirin Pharma
11.8.1 Kyowa Hakko Kirin Pharma Company Information
11.8.2 Kyowa Hakko Kirin Pharma Parkinson Disease Drug Product Offered
11.8.3 Kyowa Hakko Kirin Pharma Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2021)
11.8.4 Kyowa Hakko Kirin Pharma Main Business Overview
11.8.5 Kyowa Hakko Kirin Pharma Latest Developments
11.9 Astellas Pharma
11.9.1 Astellas Pharma Company Information
11.9.2 Astellas Pharma Parkinson Disease Drug Product Offered
11.9.3 Astellas Pharma Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2021)
11.9.4 Astellas Pharma Main Business Overview
11.9.5 Astellas Pharma Latest Developments
11.10 Desitin Arzneimittel
11.10.1 Desitin Arzneimittel Company Information
11.10.2 Desitin Arzneimittel Parkinson Disease Drug Product Offered
11.10.3 Desitin Arzneimittel Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2021)
11.10.4 Desitin Arzneimittel Main Business Overview
11.10.5 Desitin Arzneimittel Latest Developments
11. Endo Pharmaceuticals
11.11.1 Endo Pharmaceuticals Company Information
11.11.2 Endo Pharmaceuticals Parkinson Disease Drug Product Offered
11.11.3 Endo Pharmaceuticals Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2021)
11.11.4 Endo Pharmaceuticals Main Business Overview
11.11.5 Endo Pharmaceuticals Latest Developments
11.12 F.Hoffmann-La Roche
11.12.1 F.Hoffmann-La Roche Company Information
11.12.2 F.Hoffmann-La Roche Parkinson Disease Drug Product Offered
11.12.3 F.Hoffmann-La Roche Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2021)
11.12.4 F.Hoffmann-La Roche Main Business Overview
11.12.5 F.Hoffmann-La Roche Latest Developments
11.13 H.Lundbeck
11.13.1 H.Lundbeck Company Information
11.13.2 H.Lundbeck Parkinson Disease Drug Product Offered
11.13.3 H.Lundbeck Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2021)
11.13.4 H.Lundbeck Main Business Overview
11.13.5 H.Lundbeck Latest Developments
11.14 Valeant
11.14.1 Valeant Company Information
11.14.2 Valeant Parkinson Disease Drug Product Offered
11.14.3 Valeant Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2021)
11.14.4 Valeant Main Business Overview
11.14.5 Valeant Latest Developments
11.15 Apokyn
11.15.1 Apokyn Company Information
11.15.2 Apokyn Parkinson Disease Drug Product Offered
11.15.3 Apokyn Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2021)
11.15.4 Apokyn Main Business Overview
11.15.5 Apokyn Latest Developments
11.16 Orion
11.16.1 Orion Company Information
11.16.2 Orion Parkinson Disease Drug Product Offered
11.16.3 Orion Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2021)
11.16.4 Orion Main Business Overview
11.16.5 Orion Latest Developments
11.17 Stada Arzneimittel
11.17.1 Stada Arzneimittel Company Information
11.17.2 Stada Arzneimittel Parkinson Disease Drug Product Offered
11.17.3 Stada Arzneimittel Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2021)
11.17.4 Stada Arzneimittel Main Business Overview
11.17.5 Stada Arzneimittel Latest Developments
11.18 US WorldMeds
11.18.1 US WorldMeds Company Information
11.18.2 US WorldMeds Parkinson Disease Drug Product Offered
11.18.3 US WorldMeds Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2021)
11.18.4 US WorldMeds Main Business Overview
11.18.5 US WorldMeds Latest Developments
11.19 Bausch Health
11.19.1 Bausch Health Company Information
11.19.2 Bausch Health Parkinson Disease Drug Product Offered
11.19.3 Bausch Health Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2021)
11.19.4 Bausch Health Main Business Overview
11.19.5 Bausch Health Latest Developments

12 Research Findings and Conclusion

List of Tables
Table 1. Parkinson Disease Drug Market Size CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Sinemet-CR
Table 3. Major Players of Trastal
Table 4. Major Players of Madopar
Table 5. Major Players of COMT Inhibitor
Table 6. Major Players of Other
Table 7. Parkinson Disease Drug Market Size CAGR by Type (2020-2026) & ($ Millions)
Table 8. Global Parkinson Disease Drug Market Size by Type (2016-2021) & ($ Millions)
Table 9. Global Parkinson Disease Drug Market Size Market Share by Type (2016-2021)
Table 10. Parkinson Disease Drug Market Size CAGR by Application (2016-2021) & ($ Millions)
Table 11. Global Parkinson Disease Drug Market Size by Application (2016-2021) & ($ Millions)
Table 12. Global Parkinson Disease Drug Market Size Market Share by Application (2016-2021)
Table 13. Global Parkinson Disease Drug Revenue by Players (2019-2021E) & ($ Millions)
Table 14. Global Parkinson Disease Drug Revenue Market Share by Players (2019-2021E)
Table 15. Parkinson Disease Drug Key Players Head office and Products Offered
Table 16. Parkinson Disease Drug Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Parkinson Disease Drug Market Size by Regions 2016-2021 & ($ Millions)
Table 20. Global Parkinson Disease Drug Market Size Market Share by Regions 2016-2021
Table 21. Americas Parkinson Disease Drug Market Size by Country (2016-2021) & ($ Millions)
Table 22. Americas Parkinson Disease Drug Market Size Market Share by Country (2016-2021)
Table 23. Americas Parkinson Disease Drug Market Size by Type (2016-2021) & ($ Millions)
Table 24. Americas Parkinson Disease Drug Market Size Market Share by Type (2016-2021)
Table 25. Americas Parkinson Disease Drug Market Size by Application (2016-2021) & ($ Millions)
Table 26. Americas Parkinson Disease Drug Market Size Market Share by Application (2016-2021)
Table 27. APAC Parkinson Disease Drug Market Size by Region (2016-2021) & ($ Millions)
Table 28. APAC Parkinson Disease Drug Market Size Market Share by Region (2016-2021)
Table 29. APAC Parkinson Disease Drug Market Size by Type (2016-2021) & ($ Millions)
Table 30. APAC Parkinson Disease Drug Market Size Market Share by Type (2016-2021)
Table 31. APAC Parkinson Disease Drug Market Size by Application (2016-2021) & ($ Millions)
Table 32. APAC Parkinson Disease Drug Market Size Market Share by Application (2016-2021)
Table 33. Europe Parkinson Disease Drug Market Size by Country (2016-2021) & ($ Millions)
Table 34. Europe Parkinson Disease Drug Market Size Market Share by Country (2016-2021)
Table 35. Europe Parkinson Disease Drug Market Size by Type (2016-2021) & ($ Millions)
Table 36. Europe Parkinson Disease Drug Market Size Market Share by Type (2016-2021)
Table 37. Europe Parkinson Disease Drug Market Size by Application (2016-2021) & ($ Millions)
Table 38. Europe Parkinson Disease Drug Market Size Market Share by Application (2016-2021)
Table 39. Middle East & Africa Parkinson Disease Drug Market Size by Region (2016-2021) & ($ Millions)
Table 40. Middle East & Africa Parkinson Disease Drug Market Size Market Share by Region (2016-2021)
Table 41. Middle East & Africa Parkinson Disease Drug Market Size by Type (2016-2021) & ($ Millions)
Table 42. Middle East & Africa Parkinson Disease Drug Market Size Market Share by Type (2016-2021)
Table 43. Middle East & Africa Parkinson Disease Drug Market Size by Application (2016-2021) & ($ Millions)
Table 44. Middle East & Africa Parkinson Disease Drug Market Size Market Share by Application (2016-2021)
Table 45. Key and Potential Regions of Parkinson Disease Drug
Table 46. Key Application and Potential Industries of Parkinson Disease Drug
Table 47. Key Challenges of Parkinson Disease Drug
Table 48. Key Trends of Parkinson Disease Drug
Table 49. Global Parkinson Disease Drug Market Size Forecast by Regions (2021-2026) & ($ Millions)
Table 50. Global Parkinson Disease Drug Market Size Market Share Forecast by Regions (2021-2026)
Table 51. Global Parkinson Disease Drug Market Size Forecast by Type (2021-2026) & ($ Millions)
Table 52. Global Parkinson Disease Drug Market Size Market Share Forecast by Type (2021-2026)
Table 53. Global Parkinson Disease Drug Market Size Forecast by Application (2021-2026) & ($ Millions)
Table 54. Global Parkinson Disease Drug Market Size Market Share Forecast by Application (2021-2026)
Table 55. Merck Details, Company Type, Parkinson Disease Drug Area Served and Its Competitors
Table 56. Merck Parkinson Disease Drug Product Offered
Table 57. Merck Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 58. Merck Main Business
Table 59. Merck Latest Developments
Table 60. Akorn Details, Company Type, Parkinson Disease Drug Area Served and Its Competitors
Table 61. Akorn Parkinson Disease Drug Product Offered
Table 62. Akorn Main Business
Table 63. Akorn Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 64. Akorn Latest Developments
Table 65. GSK Details, Company Type, Parkinson Disease Drug Area Served and Its Competitors
Table 66. GSK Parkinson Disease Drug Product Offered
Table 67. GSK Main Business
Table 68. GSK Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 69. GSK Latest Developments
Table 70. Novartis Details, Company Type, Parkinson Disease Drug Area Served and Its Competitors
Table 71. Novartis Parkinson Disease Drug Product Offered
Table 72. Novartis Main Business
Table 73. Novartis Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 74. Novartis Latest Developments
Table 75. Boehringer Ingelheim Details, Company Type, Parkinson Disease Drug Area Served and Its Competitors
Table 76. Boehringer Ingelheim Parkinson Disease Drug Product Offered
Table 77. Boehringer Ingelheim Main Business
Table 78. Boehringer Ingelheim Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 79. Boehringer Ingelheim Latest Developments
Table 80. Teva Pharmaceutical Details, Company Type, Parkinson Disease Drug Area Served and Its Competitors
Table 81. Teva Pharmaceutical Parkinson Disease Drug Product Offered
Table 82. Teva Pharmaceutical Main Business
Table 83. Teva Pharmaceutical Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 84. Teva Pharmaceutical Latest Developments
Table 85. Abbvie Details, Company Type, Parkinson Disease Drug Area Served and Its Competitors
Table 86. Abbvie Parkinson Disease Drug Product Offered
Table 87. Abbvie Main Business
Table 88. Abbvie Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 89. Abbvie Latest Developments
Table 90. Kyowa Hakko Kirin Pharma Details, Company Type, Parkinson Disease Drug Area Served and Its Competitors
Table 91. Kyowa Hakko Kirin Pharma Parkinson Disease Drug Product Offered
Table 92. Kyowa Hakko Kirin Pharma Main Business
Table 93. Kyowa Hakko Kirin Pharma Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 94. Kyowa Hakko Kirin Pharma Latest Developments
Table 95. Astellas Pharma Details, Company Type, Parkinson Disease Drug Area Served and Its Competitors
Table 96. Astellas Pharma Parkinson Disease Drug Product Offered
Table 97. Astellas Pharma Main Business
Table 98. Astellas Pharma Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 99. Astellas Pharma Latest Developments
Table 100. Desitin Arzneimittel Details, Company Type, Parkinson Disease Drug Area Served and Its Competitors
Table 101. Desitin Arzneimittel Parkinson Disease Drug Product Offered
Table 102. Desitin Arzneimittel Main Business
Table 103. Desitin Arzneimittel Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 104. Desitin Arzneimittel Latest Developments
Table 105. Endo Pharmaceuticals Details, Company Type, Parkinson Disease Drug Area Served and Its Competitors
Table 106. Endo Pharmaceuticals Parkinson Disease Drug Product Offered
Table 107. Endo Pharmaceuticals Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 108. Endo Pharmaceuticals Main Business
Table 109. Endo Pharmaceuticals Latest Developments
Table 110. F.Hoffmann-La Roche Details, Company Type, Parkinson Disease Drug Area Served and Its Competitors
Table 111. F.Hoffmann-La Roche Parkinson Disease Drug Product Offered
Table 112. F.Hoffmann-La Roche Main Business
Table 113. F.Hoffmann-La Roche Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 114. F.Hoffmann-La Roche Latest Developments
Table 115. H.Lundbeck Details, Company Type, Parkinson Disease Drug Area Served and Its Competitors
Table 116. H.Lundbeck Parkinson Disease Drug Product Offered
Table 117. H.Lundbeck Main Business
Table 118. H.Lundbeck Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 119. H.Lundbeck Latest Developments
Table 120. Valeant Details, Company Type, Parkinson Disease Drug Area Served and Its Competitors
Table 121. Valeant Parkinson Disease Drug Product Offered
Table 122. Valeant Main Business
Table 123. Valeant Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 124. Valeant Latest Developments
Table 125. Apokyn Details, Company Type, Parkinson Disease Drug Area Served and Its Competitors
Table 126. Apokyn Parkinson Disease Drug Product Offered
Table 127. Apokyn Main Business
Table 128. Apokyn Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 129. Apokyn Latest Developments
Table 130. Orion Details, Company Type, Parkinson Disease Drug Area Served and Its Competitors
Table 131. Orion Parkinson Disease Drug Product Offered
Table 132. Orion Main Business
Table 133. Orion Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 134. Orion Latest Developments
Table 135. Stada Arzneimittel Details, Company Type, Parkinson Disease Drug Area Served and Its Competitors
Table 136. Stada Arzneimittel Parkinson Disease Drug Product Offered
Table 137. Stada Arzneimittel Main Business
Table 138. Stada Arzneimittel Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 139. Stada Arzneimittel Latest Developments
Table 140. US WorldMeds Details, Company Type, Parkinson Disease Drug Area Served and Its Competitors
Table 141. US WorldMeds Parkinson Disease Drug Product Offered
Table 142. US WorldMeds Main Business
Table 143. US WorldMeds Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 144. US WorldMeds Latest Developments
Table 145. Bausch Health Details, Company Type, Parkinson Disease Drug Area Served and Its Competitors
Table 146. Bausch Health Parkinson Disease Drug Product Offered
Table 147. Bausch Health Main Business
Table 148. Bausch Health Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 149. Bausch Health Latest Developments
List of Figures
Figure 1. Parkinson Disease Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Parkinson Disease Drug Market Size Growth Rate 2016-2026 ($ Millions)
Figure 6. Global Parkinson Disease Drug Market Size Market Share by Type in 2020
Figure 7. Parkinson Disease Drug in Under 40 Years Old
Figure 8. Global Parkinson Disease Drug Market: Under 40 Years Old (2016-2021) & ($ Millions)
Figure 9. Parkinson Disease Drug in 40-65 Years Old
Figure 10. Global Parkinson Disease Drug Market: 40-65 Years Old (2016-2021) & ($ Millions)
Figure 11. Parkinson Disease Drug in Above 65 Years Old
Figure 12. Global Parkinson Disease Drug Market: Above 65 Years Old (2016-2021) & ($ Millions)
Figure 13. Global Parkinson Disease Drug Market Size Market Share by Application in 2020
Figure 14. Global Parkinson Disease Drug Revenue Market Share by Player in 2020
Figure 15. Global Parkinson Disease Drug Market Size Market Share by Regions (2016-2021)
Figure 16. Americas Parkinson Disease Drug Market Size 2016-2021 ($ Millions)
Figure 17. APAC Parkinson Disease Drug Market Size 2016-2021 ($ Millions)
Figure 18. Europe Parkinson Disease Drug Market Size 2016-2021 ($ Millions)
Figure 19. Middle East & Africa Parkinson Disease Drug Market Size 2016-2021 ($ Millions)
Figure 20. Americas Parkinson Disease Drug Market Size Market Share by Country in 2020
Figure 21. Americas Parkinson Disease Drug Market Size Market Share by Type in 2020
Figure 22. Americas Parkinson Disease Drug Market Size Market Share by Application in 2020
Figure 23. United States Parkinson Disease Drug Market Size Growth 2016-2021 ($ Millions)
Figure 24. Canada Parkinson Disease Drug Market Size Growth 2016-2021 ($ Millions)
Figure 25. Mexico Parkinson Disease Drug Market Size Growth 2016-2021 ($ Millions)
Figure 26. APAC Parkinson Disease Drug Market Size Market Share by Regions in 2020
Figure 27. APAC Parkinson Disease Drug Market Size Market Share by Type in 2020
Figure 28. APAC Parkinson Disease Drug Market Size Market Share by Application in 2020
Figure 29. China Parkinson Disease Drug Market Size Growth 2016-2021 ($ Millions)
Figure 30. Japan Parkinson Disease Drug Market Size Growth 2016-2021 ($ Millions)
Figure 31. Korea Parkinson Disease Drug Market Size Growth 2016-2021 ($ Millions)
Figure 32. Southeast Asia Parkinson Disease Drug Market Size Growth 2016-2021 ($ Millions)
Figure 33. India Parkinson Disease Drug Market Size Growth 2016-2021 ($ Millions)
Figure 34. Australia Parkinson Disease Drug Market Size Growth 2016-2021 ($ Millions)
Figure 35. Europe Parkinson Disease Drug Market Size Market Share by Country in 2020
Figure 36. Europe Parkinson Disease Drug Market Size Market Share by Type in 2020
Figure 37. Europe Parkinson Disease Drug Market Size Market Share by Application in 2020
Figure 38. Germany Parkinson Disease Drug Market Size Growth 2016-2021 ($ Millions)
Figure 39. France Parkinson Disease Drug Market Size Growth 2016-2021 ($ Millions)
Figure 40. UK Parkinson Disease Drug Market Size Growth 2016-2021 ($ Millions)
Figure 41. Italy Parkinson Disease Drug Market Size Growth 2016-2021 ($ Millions)
Figure 42. Russia Parkinson Disease Drug Market Size Growth 2016-2021 ($ Millions)
Figure 43. Middle East & Africa Parkinson Disease Drug Market Size Market Share by Region in 2020
Figure 44. Middle East & Africa Parkinson Disease Drug Market Size Market Share by Type in 2020
Figure 45. Middle East & Africa Parkinson Disease Drug Market Size Market Share by Application in 2020
Figure 46. Egypt Parkinson Disease Drug Market Size Growth 2016-2021 ($ Millions)
Figure 47. South Africa Parkinson Disease Drug Market Size Growth 2016-2021 ($ Millions)
Figure 48. Israel Parkinson Disease Drug Market Size Growth 2016-2021 ($ Millions)
Figure 49. Turkey Parkinson Disease Drug Market Size Growth 2016-2021 ($ Millions)
Figure 50. GCC Country Parkinson Disease Drug Market Size Growth 2016-2021 ($ Millions)
Figure 51. Americas Parkinson Disease Drug Market Size 2021-2026 ($ Millions)
Figure 52. APAC Parkinson Disease Drug Market Size 2021-2026 ($ Millions)
Figure 53. Europe Parkinson Disease Drug Market Size 2021-2026 ($ Millions)
Figure 54. Middle East & Africa Parkinson Disease Drug Market Size 2021-2026 ($ Millions)
Figure 55. United States Parkinson Disease Drug Market Size 2021-2026 ($ Millions)
Figure 56. Canada Parkinson Disease Drug Market Size 2021-2026 ($ Millions)
Figure 57. Mexico Parkinson Disease Drug Market Size 2021-2026 ($ Millions)
Figure 58. Brazil Parkinson Disease Drug Market Size 2021-2026 ($ Millions)
Figure 59. China Parkinson Disease Drug Market Size 2021-2026 ($ Millions)
Figure 60. Japan Parkinson Disease Drug Market Size 2021-2026 ($ Millions)
Figure 61. Korea Parkinson Disease Drug Market Size 2021-2026 ($ Millions)
Figure 62. Southeast Asia Parkinson Disease Drug Market Size 2021-2026 ($ Millions)
Figure 63. India Parkinson Disease Drug Market Size 2021-2026 ($ Millions)
Figure 64. Australia Parkinson Disease Drug Market Size 2021-2026 ($ Millions)
Figure 65. Germany Parkinson Disease Drug Market Size 2021-2026 ($ Millions)
Figure 66. France Parkinson Disease Drug Market Size 2021-2026 ($ Millions)
Figure 67. UK Parkinson Disease Drug Market Size 2021-2026 ($ Millions)
Figure 68. Italy Parkinson Disease Drug Market Size 2021-2026 ($ Millions)
Figure 69. Russia Parkinson Disease Drug Market Size 2021-2026 ($ Millions)
Figure 70. Spain Parkinson Disease Drug Market Size 2021-2026 ($ Millions)
Figure 71. Egypt Parkinson Disease Drug Market Size 2021-2026 ($ Millions)
Figure 72. South Africa Parkinson Disease Drug Market Size 2021-2026 ($ Millions)
Figure 73. Israel Parkinson Disease Drug Market Size 2021-2026 ($ Millions)
Figure 74. Turkey Parkinson Disease Drug Market Size 2021-2026 ($ Millions)
Figure 75. GCC Country Parkinson Disease Drug Market Size 2021-2026 ($ Millions)

※본 조사보고서 [세계의 파킨슨병 치료제 시장예측 2021년-2026년] (코드 : LPI-2201K02134) 판매에 관한 면책사항을 반드시 확인하세요.

※본 조사보고서 [세계의 파킨슨병 치료제 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요.

※당 사이트에 없는 조사자료도 취급 가능한 경우가 많으니 문의 주세요!

[이하, 관련 보고서 소개]

세계의 메니에르병 치료제 파이프 라인 시장예측 2021년-2026년
LPI-2201K02225 / LP Information / 2021년 12월 / 본 조사보고서는 메니에르병 치료제 파이프 라인의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스,...According to this latest study, the 2021 growth of Meniere Disease Drug Pipeline will have significant change from previous year. By the most conservative estimates of global Meniere Disease Drug Pipeline market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx...

세계의 만성폐색성 폐질환 관련 개입성 폐질환 시장예측 2021년-2026년
LPI-2201K00159 / LP Information / 2021년 12월 / 본 조사보고서는 만성폐색성 폐질환 관련 개입성 폐질환의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일,...According to this latest study, the 2021 growth of Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease will have significant change from previous year. By the most conservative estimates of global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease market size (most likely outcome) will be a year-over-year...

세계의 윌슨병 시장예측 2021년-2026년
LPI-2201K02218 / LP Information / 2021년 12월 / 본 조사보고서는 윌슨병의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아,...According to this latest study, the 2021 growth of Wilson's Disease will have significant change from previous year. By the most conservative estimates of global Wilson's Disease market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 192.1 million in 2020. Over...

세계의 라임병 치료 시장예측 2021년-2026년
LPI-2201K00172 / LP Information / 2021년 12월 / 본 조사보고서는 라임병 치료의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Lyme Disease Treatment will have significant change from previous year. By the most conservative estimates of global Lyme Disease Treatment market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in...